PATENT CLAIM ANALYSIS

Application Number: 15966613
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "254070"]

Abstract:
The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.

Claim (Index 15):
The method of  claim 1 , wherein the proliferation disorder is prostate cancer and said method further comprises comparing the level of prostate-specific antigen (PSA) in a sample obtained from the subject following administration of the HhP inhibitor with a reference level of PSA, and wherein the level of PSA in the sample compared to the reference level of PSA is prognostic for an outcome of treatment with the HhP inhibitor.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 91.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15420283', '15966844', '15420247', '14173588', '11990729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8160597582747626
- 35 USC 102 Novelty (BERT): 0.6592316385297113
- Combined Prediction Score: 0.8003769463002576
- Mean Citation Score: 570.6201560000002
- Max Citation Score: 657.5403
- Similarity Product: 619.146429476595

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test